56
Case No COMPM.1846 - GLAXO WELLCOME SMITHKLINE.pdf
OfficialPublications EuropeanCommunitiesL-2985 LuxembourgENCase COMP/M.1846-GLAXO WELLCOME /SMITHKLI
77
Den globala effekten av Glaxo-fallet.pdf
HGSKOL JNKPINGDen gl obal effektenav Gl axo- fal etInternprissttningskonflikterna kar mellan OECD oc
25
G. Marangoni G. Fezzi - Glaxo Wellcome Italy.pdf
XIIIInternational Conference Input-OutputTechniques Macerata, Italy, 21 25August 2000 G. Marangoni V
22
Glaxo案看营销性无形资产转让定价规制问题.docx
从Glaxo案看营销性无形资产转让定价规制问题 营销性无形资产(Marketing Intangibles)具有的独特性和价值不确定性,使得如何根据正常交易原则确定关联企业间涉及营销性无形资产转让交易
16
Glaxo Best Selling Drugs - Costco Pharmacy San Leandro Fax.pptx
BestHip Hop Songs About DrugsMineralogical Society Monograph Noprescription drugs osteoarthritisbest
18
Migraine is a key growth area for Glaxo Wellcome Inc.doc
Migrainemedicine keygrowth area GlaxoWellcome Inc. (Glaxo); Britain-basedpharmaceutical company glob
1篇相似文档
15
Glaxo_案看营销性无形资产转让定价规制问题.doc
从Glaxo案看营销性无形资产转让定价规制问题 作者:廖益新(厦门大学法学院教授) 营销性无形资产(Marketing Intangibles) 具有的独特性和价值不确定性, 使得如何根据正常交易原则
24
An academic outsider´s view on the Glaxo case.ppt
academicoutsider’s view GlaxocaseEric AvenelGrenoble Applied Economics LaboratoryObjectives speech•O
5
1. On 4th June 2010, Glaxo SmithKline Ireland Ltd. submitted.pdf
eltrombopag(Revolade) chronicimmune thrombocytopenic purpura (ITP). November 2010 Summary 1. 4thJune

向豆丁求助:有没有Glaxo?

如要投诉违规内容,请联系我们按需举报;如要提出意见建议,请到社区论坛发帖反馈。